Fresenius SE KGaA (XSWX:FRE) Moat Score: 6/10 (As of Jun. 24, 2026)


XSWX:FRE Fresenius SE & Co KGaA XSWX:FRE
71 GF Score
Price CHF35.86
GF Value CHF32.85
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Fresenius SE KGaA Moat Score?

Fresenius SE KGaA XSWX:FRE 71 Moat Score is 6 as of Jun. 24, 2026. GuruFocus rates XSWX:FRE with a GF Score™ of 71/100 and a GF Value™ of CHF32.85 (Fairly Valued). The stock has 5 warning signs investors should review. Among 681 Healthcare Providers & Services companies, Fresenius SE KGaA ranks better than 99.12% on this metric.

Fresenius SE KGaA has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Fresenius SE KGaA has Narrow Moat: Fresenius has a strong narrow moat due to its market leadership in healthcare, significant regulatory barriers, and economies of scale. It benefits from brand strength and some pricing power, but lacks the exceptional dominance required for a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Fresenius SE KGaA might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Fresenius SE KGaA  (XSWX:FRE) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Fresenius SE KGaA Moat Score Related Terms

XSWX:FRE vs HCA, THC, DVA: Moat Score Comparison

For the Medical Care Facilities subindustry, Fresenius SE KGaA's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fresenius SE KGaA Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Moat Score distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's Moat Score falls into.


XSWX:FRE
71GF Score
Fresenius SE & Co KGaA XSWX:FRE
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 6 mean?
Fresenius SE KGaA (XSWX:FRE) has a Moat Score of 6 as of Jun. 24, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Fresenius SE KGaA ranks #6 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 0.90000000000001%.
Is Fresenius SE KGaA's Moat Score too high?
Fresenius SE KGaA's current Moat Score is 6. Based on the distribution chart, Fresenius SE KGaA ranks #6 out of 681 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Fresenius SE KGaA has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Moat Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #6 out of 681 companies for Moat Score. This places Fresenius SE KGaA in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Fresenius SE KGaA's current Moat Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Fairly Valued. The stock's GF Value™ is CHF32.85, compared to a current price of CHF35.86 — trading 9.2% above its estimated fair value. The current Moat Score is 6. Fresenius SE KGaA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current Moat Score is 6 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued. The current stock price of CHF35.86 is trading 9.2% above its estimated GF Value™ of CHF32.85. GuruFocus considers Fresenius SE KGaA to be Fairly Valued.

Key valuation signals for XSWX:FRE:

  • Moat Score: 6
  • GF Value™: CHF32.85 vs. price of CHF35.86 (9.2% above fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius SE KGaA Business Description

Address Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
71GF Score

Get the complete analysis for XSWX:FRE

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF35.86
Price
CHF32.85
GF Value